777 related articles for article (PubMed ID: 30045790)
1. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
2. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
3. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
[TBL] [Abstract][Full Text] [Related]
4. Individualized dosing of vancomycin in geriatric patients.
Suchánková H; Lečbychová K; Strojil J; Fürst T
Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of vancomycin for appropriate dosing in severe infective patients with augmented renal clearance].
Liu N; Zhang B; Liu Y; Tang J; Dong D; Gu Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):646-651. PubMed ID: 30045791
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
Joseph K; Ramireddy K; Madison G; Turco T; Lui M
J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study.
Lu H; Duan L; Yu Y; Li J; Shi L; Xue S; Zhang Q; Zhou Q; Zhu C; Shang E; Yan X; Tang L
J Chemother; 2022 Nov; 34(7):446-458. PubMed ID: 35773225
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
9. [Clinical verification of vancomycin population pharmacokinetics in patients with augmented renal clearance].
Lu H; Tang L; Xue S; Zhuang Z; Fang J; Zhao F; Shang E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 May; 30(5):444-448. PubMed ID: 29764549
[TBL] [Abstract][Full Text] [Related]
10. [Study on the optimization of administration regimen of vancomycin in critical patients].
Shi Y; He J; Mao E; Bian X; Zhou J; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):140-144. PubMed ID: 32274995
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of vancomycin in patients with severe acute pancreatitis and its influencing factors: analysis of 7 years data].
He J; Mao E; Jing F; Jiang H; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):491-495. PubMed ID: 28625235
[TBL] [Abstract][Full Text] [Related]
12. Impact of vancomycin therapeutic drug monitoring on patient care.
Welty TE; Copa AK
Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center.
Marquis KA; DeGrado JR; Labonville S; Kubiak DW; Szumita PM
Ann Pharmacother; 2015 Sep; 49(9):1009-14. PubMed ID: 25991831
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
16. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
18. [High dose vitamin C significantly reduces the nephrotoxicity of vancomycin in critically ill patients].
He J; Mao E; Xu W; Zhao B; Jing F; Bian X; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):468-472. PubMed ID: 32527355
[TBL] [Abstract][Full Text] [Related]
19. [Predictive performance of Smart Dose, PharmVan and JPKD on Vancomycin plasma concentration].
Han L; Xu F; Zhang X; Wang Y; Lin G; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):263-268. PubMed ID: 33834965
[TBL] [Abstract][Full Text] [Related]
20. Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
Momattin H; Zogheib M; Homoud A; Al-Tawfiq JA
Chemotherapy; 2016; 61(1):3-7. PubMed ID: 26555724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
